Dr. Charles is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
60 Fenwood Road, Room 5016L
Departments of Orthopaedic Surgery and Medicine
Boston, MA 02115Phone+1 617-732-5325Fax+1 617-732-5766
Education & Training
- University of California (San Francisco)Fellowship, Rheumatology, 2004 - 2007
- Brigham and Women's HospitalResidency, Internal Medicine, 2002 - 2004
- University of California San Francisco School of MedicineClass of 2001
Certifications & Licensure
- FL State Medical License 2022 - 2027
- MA State Medical License 2011 - 2026
- NH State Medical License 2023 - 2025
- CA State Medical License 2004 - 2011
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- Maresin 1-LGR6 axis mitigates inflammation and posttraumatic osteoarthritis after transection of the anterior cruciate ligament in mice.Chilan B G Leite, Hannah P Fricke, Luciana P Tavares, Robert Nshimiyimana, Julie Mekhail
Osteoarthritis and Cartilage. 2025-03-24 - Effective and Engaging Active Learning in the Medical School Classroom: Lessons from Case-Based Collaborative Learning.Henrike C Besche, Randall W King, Keri M Shafer, Sarah E Fleet, Julia F Charles
Journal of Medical Education and Curricular Development. 2025-01-28 - Bone loss with aging is independent of gut microbiome in mice.Xiaomeng You, Jing Yan, Jeremy Herzog, Sabah Nobakhti, Ross Campbell
Bone Research. 2024-11-11
Journal Articles
- Peripartum Fluoxetine Reduces Maternal Trabecular Bone Post-Weaning and Elevates Mammary Gland Serotonin and PTHrPJulia Charles, MD, Endocrinology
- Costimulatory blockade to prevent osteoclastogenesis, inflammation or both?Charles, J.F. and M.C. Nakamura, Bone Key
Grant Support
- Mechanisms of bone fragility in Autosomal Dominant Osteopetrosis type II: from human to mouse and backBRIGHAM AND WOMEN'S HOSPITAL2022–2027
- Mechanisms of bone fragility in Autosomal Dominant Osteopetrosis type II: from human to mouse and backBRIGHAM AND WOMEN'S HOSPITAL2022–2027
- Osteoclasts or RANKL: Which is the critical target in treatment of fibrous dysplasia bone lesions?BRIGHAM AND WOMEN'S HOSPITAL2024–2026
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: